Anna Brichkina

813 total citations
26 papers, 546 citations indexed

About

Anna Brichkina is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Anna Brichkina has authored 26 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Anna Brichkina's work include Epigenetics and DNA Methylation (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Neuroblastoma Research and Treatments (3 papers). Anna Brichkina is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Neuroblastoma Research and Treatments (3 papers). Anna Brichkina collaborates with scholars based in Germany, Russia and Singapore. Anna Brichkina's co-authors include Dmitry V. Bulavin, Dmitry A. Gorin, Maria N. Antipina, Weiping Han, Elena Kostromina, Xavier Le Guezennec, Anton M. Pavlov, Gleb B. Sukhorukov, Maxim V. Kiryukhin and Elena N. Vasina and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Genes & Development and Cell Metabolism.

In The Last Decade

Anna Brichkina

26 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Brichkina Germany	10	243	94	91	83	82	26	546
Hyang‐Hwa Ryu South Korea	15	277 1.1×	129 1.4×	112 1.2×	106 1.3×	113 1.4×	27	699
Elisa Pedone United Kingdom	16	594 2.4×	60 0.6×	38 0.4×	103 1.2×	104 1.3×	29	910
Dejun Yang China	20	452 1.9×	129 1.4×	69 0.8×	128 1.5×	138 1.7×	44	899
Ju-Ock Nam South Korea	12	475 2.0×	159 1.7×	32 0.4×	121 1.5×	85 1.0×	15	810
Prajna Mishra India	12	368 1.5×	167 1.8×	35 0.4×	158 1.9×	130 1.6×	14	697
Dongjun Luo China	8	274 1.1×	62 0.7×	62 0.7×	68 0.8×	95 1.2×	10	558
Łukasz Mielańczyk Poland	16	273 1.1×	53 0.6×	23 0.3×	48 0.6×	69 0.8×	30	538
Tessa M. Simone United States	12	305 1.3×	100 1.1×	59 0.6×	52 0.6×	79 1.0×	20	608
Douglas A. Chapnick United States	13	497 2.0×	49 0.5×	67 0.7×	145 1.7×	119 1.5×	19	840

Countries citing papers authored by Anna Brichkina

Since Specialization

Citations

This map shows the geographic impact of Anna Brichkina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Brichkina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Brichkina more than expected).

Fields of papers citing papers by Anna Brichkina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Brichkina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Brichkina. The network helps show where Anna Brichkina may publish in the future.

Co-authorship network of co-authors of Anna Brichkina

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Brichkina. A scholar is included among the top collaborators of Anna Brichkina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Brichkina. Anna Brichkina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gomzikova, Marina, et al.. (2025). Mitochondrial, metabolic and bioenergetic adaptations drive plasticity of colorectal cancer cells and shape their chemosensitivity. Cell Death and Disease. 16(1). 253–253. 2 indexed citations

Gomzikova, Marina, et al.. (2025). Comprehensive analysis of cellular metrics: From proliferation to mitochondrial membrane potential and cell death in a single sample. Cell Death Discovery. 11(1). 119–119. 2 indexed citations

Mukhamedshina, Yana, et al.. (2025). Immunometabolism of tumor-associated macrophages: A therapeutic perspective. European Journal of Cancer. 220. 115332–115332. 11 indexed citations

Brichkina, Anna, et al.. (2025). A safe haven for cancer cells: tumor plus stroma control by DYRK1B. Oncogene. 44(6). 341–347. 2 indexed citations

Gomzikova, Marina, Yana Mukhamedshina, Matthias Lauth, et al.. (2024). In vitro functional assays to assess the reciprocal interplay between tumor cells and macrophages. The FASEB Journal. 38(13). e23730–e23730. 1 indexed citations

Brichkina, Anna, Rajeev Singh, Veronika Lutz, et al.. (2024). DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. Gut. 73(10). 1684–1701. 8 indexed citations

Gomzikova, Marina, et al.. (2024). Mitochondrial Protein Density, Biomass, and Bioenergetics as Predictors for the Efficacy of Glioma Treatments. International Journal of Molecular Sciences. 25(13). 7038–7038. 1 indexed citations

Enukashvily, N. I., Andrey D. Prjibelski, Sabrina Elmshäuser, et al.. (2023). Pericentromeric satellite lncRNAs are induced in cancer-associated fibroblasts and regulate their functions in lung tumorigenesis. Cell Death and Disease. 14(1). 19–19. 12 indexed citations

Brichkina, Anna, et al.. (2023). A Quick Guide to CAF Subtypes in Pancreatic Cancer. Cancers. 15(9). 2614–2614. 23 indexed citations

10.

Brichkina, Anna, Florian Finkernagel, Alexander Visekruna, et al.. (2023). Tumor-suppressive disruption of cancer subtype-associated super enhancer circuits by small molecule treatment. NAR Cancer. 5(1). zcad007–zcad007. 2 indexed citations

11.

Brichkina, Anna & Hans‐Uwe Simon. (2023). A novel role for mitochondrial fission in macrophages: trained innate immunity induced by beta-glucan. Cellular and Molecular Immunology. 20(8). 864–866. 7 indexed citations

12.

Brichkina, Anna, et al.. (2021). DYRK3 contributes to differentiation and hypoxic control in neuroblastoma. Biochemical and Biophysical Research Communications. 567. 215–221. 7 indexed citations

13.

Brichkina, Anna, et al.. (2021). The mammalian Hedgehog pathway is modulated by ANP32 proteins. Biochemical and Biophysical Research Communications. 553. 78–84. 5 indexed citations

14.

Brichkina, Anna, Florian Finkernagel, Andrea Nist, et al.. (2021). Activation of Cilia-Independent Hedgehog/GLI1 Signaling as a Novel Concept for Neuroblastoma Therapy. Cancers. 13(8). 1908–1908. 9 indexed citations

15.

Brichkina, Anna, Thomas Bertero, Alexander Emelyanov, et al.. (2016). p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis. Genes & Development. 30(23). 2623–2636. 41 indexed citations

16.

Brichkina, Anna, Rajamanickam Baskar, Sheena Wee, et al.. (2016). Proline isomerisation as a novel regulatory mechanism for p38MAPK activation and functions. Cell Death and Differentiation. 23(10). 1592–1601. 16 indexed citations

17.

Lomova, Maria V., Anna Brichkina, Maxim V. Kiryukhin, et al.. (2015). Multilayer Capsules of Bovine Serum Albumin and Tannic Acid for Controlled Release by Enzymatic Degradation. ACS Applied Materials & Interfaces. 7(22). 11732–11740. 137 indexed citations

18.

Brichkina, Anna, et al.. (2014). Novel mechanism of JNK pathway activation by adenoviral E1A. Oncotarget. 5(8). 2176–2186. 5 indexed citations

19.

Guezennec, Xavier Le, et al.. (2012). Wip1-Dependent Regulation of Autophagy, Obesity, and Atherosclerosis. Cell Metabolism. 16(1). 68–80. 113 indexed citations

20.

Brichkina, Anna & Dmitry V. Bulavin. (2012). WIP-ing out atherosclerosis with autophagy. Autophagy. 8(10). 1545–1547. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact